Syncom Formulations (India) Ltd Share Price

Pharmaceuticals - Indian - Formulations

NSE: SYNCOMF Small Cap ISIN: INE312C01025

As on 22 January 2025 at 18:37 IST

₹18.12

-0.27

(-1.47%)

Sell Buy

Over 1 Month

-8.82%

Over 6 Months

22.11%

Over 1 Year

21.79%

Over 3 Years

127.04%

Syncom Formulations (India) Ltd Summary

Close ₹ 18.12

Open ₹ 18.40

High ₹ 18.49

Low ₹ 17.70

Volume 14,92,774

Net Turnover (in ₹) ₹ 3,23,47,099.06

52Wk High ₹ 27.90

52Wk Low ₹ 10.95

52Wk High / Low

10.95

27.90

Syncom Formulations (India) Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,728.66

EPS (TTM) 0.34

Book Value (BV) 3.32

Div. Yield -

P/E (TTM) 54.09

Price/Book Value 5.55

Delivery % 49.77 %

Face Value 1

Key Ratios

PE Ratio 44.72

PB Ratio 3.67

EV to Sales 4.08

PEG Ratio 2.35

ROA 6.50

ROE 8.71

Debt-Equity 0.29

Net Profit Margin 9.14

Operating Profit Margin 15.94

Syncom Formulations (India) Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016
Total Revenue	276.91	238.85	231.66	187.61	186.57
Total Expenses	242.94	212.29	205.50	171.73	170.36
Profit Before Tax	33.95	26.57	26.18	15.88	16.10
Profit After Tax	25.31	20.07	19.79	10.53	10.36
Operating Profit after Depreciation	38.45	29.69	28.08	16.17	16.27

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016
Fixed Assets	72.42	43.40	46.61	55.04	45.85
Total Non Current Assets	129.88	196.14	168.44	97.38	88.99
Total Current Assets	274.78	181.69	139.80	82.79	86.42
TOTAL ASSETS	404.66	377.83	308.24	180.17	175.41
Total Shareholder's Fund	288.14	256.01	222.22	117.35	108.70

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016
Net Cash from Operating Activities	-5.96	10.53	16.33	13.84	24.07
Net Cash used in Investing Activities	83.02	-44.95	-27.07	-17.68	-22.74
Net Cash used in Financing Activities	-14.56	35	8.29	4.67	-2.41

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	271.46	239.25	231.66	251.95	210.73
Total Expenses	239.68	212.70	205.50	211.27	193.39
Profit Before Tax	31.76	26.57	26.18	40.70	17.29
Profit After Tax	23.62	20.07	19.79	29.17	14.25
Operating Profit after Depreciation	36.23	29.68	28.08	41.03	17.89

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	72.42	43.40	46.61	44.32	45.98
Total Non Current Assets	128.86	196.17	168.44	101.81	94.54
Total Current Assets	262.64	180.77	139.80	189.84	85.98
TOTAL ASSETS	391.50	376.94	308.24	291.65	180.52
Total Shareholder's Fund	286.45	256.01	222.22	187.58	145.65

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-5.94	10.50	16.33	-2.06	5.86
Net Cash used in Investing Activities	83.83	-44.97	-27.07	-75.35	1.51
Net Cash used in Financing Activities	-15.37	35	8.29	71.96	-6.52

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	102.31	86.29	74.57	65.14	63.84
Total Expenses	90.15	76.80	65.15	57.78	57.43
Profit Before Tax	14.85	10.11	10.02	9.37	8.45
Profit After Tax	11.11	7.63	7.40	7	6.51
Operating Profit after Depreciation	16.31	11.80	12.52	11.92	10.41

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	101.49	85.86	73.27	63.34	62.39
Total Expenses	89.56	76.36	64.46	56.54	56.29
Profit Before Tax	14.65	10.09	9.21	8.60	8.14
Profit After Tax	10.95	7.63	6.75	6.42	6.21
Operating Profit after Depreciation	16.11	11.78	11.68	11.15	10.10

Syncom Formulations (India) Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 18.04

S2 17.70

S3 17.21

Pivot 18.53

R1 18.87

R2 19.36

R3 19.70

Moving Average

20 SMA 19.23

50 SMA 20.30

100 SMA 20.94

200 SMA 17.49

Syncom Formulations (India) Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 19 Sep 2022

AGM 19/09/2022 Outcome of the 5/2022-23 Meeting of the Board of Directors of the Company held on Saturday, 13th August, 2022 at 207, Saket Nagar, Near Saket Club, Indore (M.P.) 452018 at 4:00 P.M. as per Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015. We are pleased to inform you that pursuant to the provisions of Regulation 42 of SEBI (LODR) Regulations, 2015 read with the provisions of section 91 of the Companies Act, 2013 the Register of Members and Share transfer books of the Company shall remain closed from Tuesday, 13thSeptember, 2022 to Monday, 19th September, 2022 (both days inclusive) for the purpose of the ensuing 34thAnnual General Meeting of the Company to be held on Monday, 19th September, 2022, through Video Conferencing / Other Audio Visual Means (VC)/(OAVM) and ascertain the entitlement for payment of dividend @ Rs.0.03/- (3%) per equity share of Rs.1/- each for the year 2021-22, if any, subject to approval by the members at their above said Annual General Meeting. We hereby submit the following information''s for the investors/ members of the Company:- Sr.No. Heading Particulars 1 Name of the Agency providing E-voting platform CDSL 2 Name of the Agency providing E-voting facility at AGM and VC/OAVM platform CDSL 3 Cut-off date for E-voting entitlement 12.09.2022 4 Voting Start Date & Time 16.09.2022 at 9:00 A.M. (IST) 5 Voting End Date & Time 18.09.2022 at 5:00 P.M. (IST) 6 Name of the Scrutinizers CS Anish Gupta Practicing Company Secretary We are pleased to submit a copy of the Notice of the 34th Annual General Meeting of the Company to be held on Monday, the 19th day of September, 2022 at 2:00 P.M. through Video Conferencing (VC)/Other Audio Visual Means (OAVM) for which purpose the Registered Office of the Company situated at 7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (East) Mumbai (M.H.) 400093 shall be deemed as the venue for the meeting and the proceedings of the AGM shall be deemed to be made thereat. You are requested to please take on record the above said document for your reference and further needful. This is in continuation of our letter no. SYNCOM/SE/2022-23 dated 13th August, 2022 regarding Submission of the 34th AGM Notice for the Year ended 31st March, 2022. We hereby inform that due to Typographical error in the Item No. 6 along with the Explanatory Statement of the same in the said Notice, in the Item No.6 the Word an Ordinary Resolution shall be read as a Special Resolution and in the Explanatory Statement for Item No. 6 to be read as a Special Resolution where ever it appears.. Copy of revised 34th AGM Notice for the Year ended 31st March, 2022 is enclosed for your reference, and ignore the previous AGM Notice. You are requested to take on record and upload at the portal of BSE for your reference and record. (As Per BSE Announcement Dated on 18.08.2022) Please find enclosed herewith copy of the Newspaper Clippings of Notice of 34th Annual General Meeting (AGM), Remote E-voting and Book Closure and other details as published in 'Navshakti Maratha' (Mumbai Edition Local in Marathi) & 'Free Press' (Mumbai English Edition) on Tuesday, 30th August, 2022. You are requested to please take on record the above said documents for your reference and further needful. (As Per BSE Announcement Dated on 30/08/2022) Pursuant to the Regulation 30(2) read with Part A of Schedule III of the SEBI (LODR) Regulations, 2015 we are pleased to submit the proceedings of the 34th Annual General Meeting of Syncom Formulations (India) Limited duly held on Monday,19th September, 2022 at 2:00 P.M. (IST) and concluded at 2:52 P.M. (IST) through Video Conferencing or Other Audio Video Means (VC/OAVM) for which purposes the Registered office of the company situated at 7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (East) Mumbai- 400 093 (M.H.) shall be deemed as the venue for the Meeting. Please note that the results of e-voting will be intimated to you separately upon receipt of Report from the Scrutinizer within two Working days from the conclusion of the Annual General Meeting. (As Per BSE Announcement Dated on 20.09.2022) With reference to the captioned subject, we hereby submit the results of (remote e-voting and E-voting at AGM) of 34th Annual General Meeting of the Company held on Monday, 19th September, 2022 at 2:00 P.M. (IST) and concluded at 2:52 P.M. (IST) through Video Conferencing and Other Audio Visual Means (VC/OAVM). Kindly note that the Chairman has declared the result of voting of the aforesaid Annual General Meeting on 21st September, 2022 on the basis of report submitted by the Scrutinizer for remote e-voting and e-voting at AGM for the above mentioned purpose. We are in the process of filing the aforesaid results in XBRL mode. We are also enclosing the Scrutinizer's Report and request you to please take the same on your records for reference and further needful. Corporate Announcement for approval of Final Dividend Rs. 0.03 (3.00%) on the 94,00,00,000 Equity Shares of Rs.1/- each of the Company by the Members for the year 2021-22 and dispatch of the Dividend Warrants/DDs. Declaration of Results of Remote E-voting and E-voting at Annual General Meeting, in compliance with Regulation 44(3) of SEBI (LODR) Regulation, 2015 in relation to the 34th Annual General Meeting of the Company held on 19th September, 2022 Outcome of the 34th Annual General Meeting of the Company held on Monday, 19th September, 2022 (As Per BSE Announcement Dated on 21.09.2022)

AGM Date: 26 Sep 2023

AGM 26/09/2023 Notice of 35th AGM of the Company to be held on Tuesday 26th September, 2023 at 3:00 P.M through VC/OAVM. (As Per BSE Announcement Dated on 29/08/2023) Pursuant to provisions of regulation 34(1) of the SEBI (LODR) Regulations, 2015, we are pleased to submit the 35thAnnual Report for the year 2022-23 of the Company containing the Balance Sheet as at 31st March, 2023, Statement of Changes in Equity and the Statement of the Profit and Loss and Cash Flow for the year ended 31st March, 2023 and the Boards' Report along with Corporate Governance Report, Business Responsibility And Sustainability Report (BRSR) and the Auditors' Report on that date and its annexures. Kindly note that the 35th Annual General Meeting of the Company is scheduled to be held on Tuesday, 26th September, 2023 at 3:00 P.M. through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM'). The above-mentioned documents are available on the Company's website at www.sfil.in (As Per BSE Announcement Dated on 04/09/2023) Proceedings of 35th Annual General Meeting of the Company (As Per BSE Announcement Dated on 26/09/2023) Outcome of the 35th Annual General Meeting (As per BSE Announcement Dated on 28/09/2023) Submission of Minutes of Annual General Meeting held on 26.09.2023 (As per BSE Announcement Dated on 26/10/2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 We hereby submit the Voting Results of the 36th Annual General Meeting held on 30.09.2024 alongwith the Scrutiniser Report submitted to the company on 03.10.2024. (As Per BSE Announcement dated on 03.10.2024) Submission of the Minutes of the 36th Annual General Meeting held on 30th September, 2024 (As per BSE Announcement Dated on 17/10/2024)

Syncom Formulations (India) Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Syncom Formulations (India) Ltd	₹18.39	₹1,728.66
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Syncom Formulations (India) Ltd News

Syncom Formulations (India) to convene board meeting

On 11 November 2024

05 Nov 2024, 02:12 pm

Syncom Formulations (India) schedules AGM

On 30 September 2024

20 Sep 2024, 05:48 pm

Syncom Formulations (India) to hold AGM

On 30 September 2024

20 Sep 2024, 10:30 am

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Syncom Formulations (India) added 1.94% to Rs 16.29 after the company reported 73.4% increase in consolidated net profit to Rs 7.63 crore in Q1 FY25 from Rs 4.40 crore in Q1 FY24.

13 Aug 2024, 01:37 pm

Syncom Formulations (India) announces board meeting date

On 12 August 2024

06 Aug 2024, 11:37 am

Syncom Formulations (India) Ltd Stock Analysis

Annual revenue for Syncom Formulations (India) Ltd increased by 13.46% to ₹271.46 crore in FY 2024 from ₹239.25 crore in FY 2023.
Annual Net Profit for Syncom Formulations (India) Ltd increased by 17.70% to ₹23.62 crore in FY 2024 from ₹20.07 crore in FY 2023.
Promoter Shareholding in Syncom Formulations (India) Ltd remains unchanged by 0.00% in the most recent quarter, from 50.57% in September 2024 to 50.57% in December 2024.
Syncom Formulations (India) Ltd delivered a 1-year return of 21.79% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Syncom Formulations (India) Ltd share price moved down by 1.47% from its previous close of INR ₹18.39. The latest Syncom Formulations (India) Ltd share price is INR ₹18.12.
Syncom Formulations (India) Ltd share price today has been at a low of 17.70 and a high of 18.49. Over the past 52 weeks, the Syncom Formulations (India) Ltd share price has seen a low of 10.95 and a high of 27.90.